Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology Cannabis Investing News
Seelos Therapeutics Doses First Patient in Part 2 of a Registrational Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
COMPASS Pathways joins forces with King's College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK Psychedelics Investing
Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets Cannabis Investing News
Better Plant Collaborates With Beauty Night Society With Limited Edition Asana Body & Massage Oil Cannabis Investing News
COMPASS Pathways launches new podcast "Everyone has a story: talking about mental health" Psychedelics Investing
MCOA Subsidiary cDistro Signs Distribution Agreement with Silo Wellness and Marley One Functional Mushrooms Psychedelics Investing
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US Psychedelics Investing
Hollister Biosciences Inc. Announces Launch of Pre-Roll Production and Distribution in Arizona Psychedelics Investing
Awakn Life Sciences Files Patent Applications in U.S. for AWKN001 and AWKN002, Two Next-Generation New Chemical Entities [NCES] to Treat a Broad Range of Addiction Indications Psychedelics Investing
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression Psychedelics Investing
